For months, Americans were told by many scientists and media that lockdowns were necessary until a vaccine for COVID-19 was available, even though it was unclear when that would be.
Two vaccines have since been approved for use, but the virus is claiming lives faster than ever in large part because officials are struggling to distribute them fast enough.
Medical experts say the bottleneck could be loosened if the Food and Drug Administration approved Oxford-AstraZeneca, a vaccine developed by Oxford researchers that is more affordable than other vaccines currently available and far easier to distribute.
"The FDA needs to stop playing games and authorize the Oxford-AstraZeneca vaccine. It's safe, cheap ($2-$3 a dose), and is the easiest vaccine to distribute," says Dr. Marty Makary, a professor of surgery and health policy at the Johns Hopkins University School of Medicine. "It does not require freezing and is already approved and being administered in the United Kingdom."